J Chen

MDM2 oncogene as a target for cancer therapy: An antisense approach.

Haowei Wang, Xiaorong Zeng, Patsy G. Oliver et al. · International Journal of Oncology · 1999 · 82 citations

Cancer Therapy, Immunology, Cell Death +18

LKB1 inhibits HPV-associated cancer progression by targeting cellular metabolism

Qinghua Zeng, J Chen, Yong Li et al. · Oncogene · 2016 · 69 citations · Full text

Tumor Biology, Medicine, Tumor Suppressor +7

Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin

Shannon Elf, Richard Z. Lin, Siyuan Xia et al. · Oncogene · 2016 · 62 citations · Full text

Oxidative Ppp, Biochemistry, Antiparasitic Agent +8

Targeting 14-3-3 sensitizes native and mutant BCR-ABL to inhibition with U0126, rapamycin and Bcl-2 inhibitor GX15-070

Shuze Dong, Sumin Kang, Sagar Lonial et al. · Leukemia · 2007 · 36 citations · Full text

Molecular Pharmacology, Mutant Bcr-abl, Medicine +10

Fyn-phosphorylated PIKE-A binds and inhibits AMPK signaling, blocking its tumor suppressive activity

S Zhang, Qi Qi, Chi Bun Chan et al. · Cell Death and Differentiation · 2015 · 35 citations · Full text

Fyn-phosphorylated Pike-a Binds, Signal Transduction, Cell Regulation +11